|
|
|
4. Adverse effects of levodopa/carbidopa intrajejunal gel treatmentTomaž Rus, Maša Premzl, Nina Zupančič-Križnar, Milica Gregorič Kramberger, Robert Rajnar, Lidija Ocepek, Zvezdan Pirtošek, Maja Trošt, 2022, original scientific article Keywords: advanced Parkinson's disease, levodopa-carbidopa intestinal gel, percutaneous endoscopic gastrojejunostomy, adverse effects, health-related quality of life
Full text (file, 1,14 MB) This document has more files! More... |
5. Dopaminergic pathway genes influence adverse events related to dopaminergic treatment in Parkinson's diseaseSara Redenšek Trampuž, Dušan Flisar, Maja Kojović, Milica Gregorič Kramberger, Dejan Georgiev, Zvezdan Pirtošek, Maja Trošt, Vita Dolžan, 2019, original scientific article Keywords: Parkinson's disease, genetic polymorphism, dopaminergic pathway, personalized medicine, adverse events
Full text (file, 411,70 KB) This document has more files! More... |
6. Genetic variability of inflammation and oxidative stress genes does not play a major role in the occurrence of adverse events of dopaminergic treatment in Parkinson's diseaseSara Redenšek Trampuž, Dušan Flisar, Maja Kojović, Milica Gregorič Kramberger, Dejan Georgiev, Zvezdan Pirtošek, Maja Trošt, Vita Dolžan, 2019, original scientific article Keywords: Parkinson's disease, susceptibility, polymorphism, inflammation, oxidative stress, adverse events
Full text (file, 673,75 KB) This document has more files! More... |
7. Genetic polymorphisms in oxidative stress and inflammatory pathways as potential biomarkers in Alzheimer’s disease and dementiaDavid Vogrinc, Milica Gregorič Kramberger, Andreja Emeršič, Saša Čučnik, Katja Goričar, Vita Dolžan, 2023, original scientific article Keywords: Alzheimer’s disease, oxidative stress, inflammation, polymorphism, biomarker
Full text (file, 1,14 MB) This document has more files! More... |
8. Investigation of paraoxonase-1 genotype and enzyme-kinetic parameters in the context of cognitive impairment in Parkinson’s diseaseBoštjan Petrič, Sara Redenšek Trampuž, Vita Dolžan, Milica Gregorič Kramberger, Maja Trošt, Nikola Maraković, Marko Goličnik, Aljoša Bavec, 2023, original scientific article Keywords: Parkinson disease, cognitive impairment, paraoxonase 1, paraoxonase activity, single-nucleotide polymorphisms, iFIT
Full text (file, 1,14 MB) This document has more files! More... |
9. Validation of the Slovenian version of the Montreal Cognitive Assessment Scale as a screening tool for the detection of mild cognitive impairmentAndreja Špeh, Irena Kalar, Zvezdan Pirtošek, Milica Gregorič Kramberger, 2024, original scientific article Keywords: mild cognitive impairment, MoCA, screening, cognition, elderly
Full text (file, 435,23 KB) This document has more files! More... |
10. The association of selected GWAS reported AD risk loci with CSF biomarker levels and cognitive decline in Slovenian patientsDavid Vogrinc, Milica Gregorič Kramberger, Andreja Emeršič, Saša Čučnik, Katja Goričar, Vita Dolžan, 2023, original scientific article Keywords: Alzheimer's disease, mild cognitive impairment, polymorphism, biomarker
Full text (file, 1,48 MB) This document has more files! More... |
